The cyclin-dependent kinase inhibitors p16, p21, and p27 in human brain, an
d brain tumors were examined to explore clinicopathologic correlations. Wes
tern analysis and immunohistochemistry was performed and correlated retrosp
ectively with the patients clinical characteristics. A trend was found betw
een increased progression-free survival and p27 expression. There was no co
rrelation between p27 expression and age or gender. The expression of p27 i
n malignant gliomas may have prognostic value. In addition, an investigatio
n of the therapeutic benefit of overexpression of this cyclin-dependent kin
ase inhibitor is warranted given reports of diminished malignant potential
of tumors expressing p27.